Citigroup recently reiterated its buy rating and $15 price target on Anthera's stock. Anthera Pharmaceuticals (NASDAQ:ANTH) is a tiny biotech that trades primarily on hope at this point. The company's stock price moved …
Investors in Anthera Pharmaceuticals, Inc. ANTH need to pay close attention to the stock based on moves in the options market lately. That is because the January 20th, 2017 $1 Put had some of the highest implied volatility of all equity …
Sign-up for a FREE trial here. Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of Craig Thompson as President and Chief Operating Officer. In this role Mr. Thompson will oversee both of Anthera’s late stage …
The current line up features Bas, who speaks four languages, Jaimesha, an …
“History has long been used by the elite to maintain their status in politics,” said Anusorn Unno, Dean of the Faculty of Sociology and Anthropology at …
We had alerted our premium subscribers to this stock on January 29, 2018, when it was trading around $4.79. -- On September 28, 2017, the Company made its debut on The NASDAQ Global Select Market, offering its American …
Investors in Anthera Pharmaceuticals, Inc. ANTH need to pay close attention to the stock based on moves in the options market lately. That is because the April 21 st, 2017, $1 Call had some of the highest implied volatility of all equity …
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) traded down about 85% Monday and posted a new 52-week and all-time low of $0.40 after closing Friday at $2.64. The stock’s 52-week high is $5.60. Volume was more than 30 times the daily …
Photograph: Jose A Astor/Alamy Stock Photo The ingrained notion – that there …
April 4th was the 50th anniversary of the death of Dr. Martin Luther King Jr. It is …